Clinical Trial Update: Predictors of Response to Combined Pegylated Interferon and Ribavirin in Chronic Hepatitis C Infected Egyptian Patients

View source ↗

Summary

Clinical trial exploring predictors of response to combined pegylated interferon and ribavirin in adults with chronic hepatitis C in Egypt.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Pegylated interferon (pegylated interferon alfa)
• Ribavirin (ribavirin)

Snippet

Sponsor: Cairo University | Conditions: Hepatitis C, Chronic | Status: UNKNOWN